chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac failure, Cardiac failure congestive, Chest X-ray abnormal, Condition aggravated, Coronary artery disease
Clinical narrative: Patient is a 74 y.o. male patient with history of Hypertension, diabetes, morbid obesity, OSA presented with shortness of breath.  He was found to be COVID positive and briefly required BIPAP and was able to be quickly weaned back to his home O2.  He was seen by Pulmonology and is stable for discharge from their standpoint.  He also was noted to have HAGMA, LA and AKI which all resolved with IVF.  PT and OT were consulted and family requesting HHC.  He is otherwise stable for discharge home and outpatient follow-up as above.  All questions and concerns answered at bedside with patient and his wife present.     Sepsis present on admit Covid-19 Virus Infection SIRS on admit, lactate 3.1, with AKI Hemodynamics stable and given CHF/COVID will avoid 30 ml/kg bolus Will hydrate with maintenance IVF and follow lactate, hemodynamics, and SCr closely Date of onset of symptoms: 10/3/22 Symptoms present on admission: cough, dyspnea Date of covid positive test: 10/4/2022 Vaccination status: vaccinated and 1 booster Imaging: CXR nonacute but low lung volumes. No definite focal consolidation Oxygen requirements on admission: 4LNC home O2 baseline Current oxygen requirements: Was on BiPAP now back to home O2 at 4 L NC Medical therapy: decadron remdesivir, albuterol MDI, guaifenesin/dextromethorphan Consultants following: None  Anticipated special isolation end date: 10/14/2022 CRP 64 Procalcitonin wnl Discharge on dexamethasone to complete 10 days steroid course   Lactic acidosis, resolved Lactic acid 4.3 now down to 3.4 Resolved with IVF   Acute renal failure, resolved SCr 1.68 from baseline 0.8-1.0 Due to COVID infection and home diuretics, ACEi Held home lasix, bumex, and lisinopril Avoid nephrotoxins, and provide gentle IVF hydration, encourage PO intake SCr normalized with IVF Can resume home regimen on discharge  Acute on Chronic respiratory failure Obesity hypoventilation syndrome Obstructive sleep apnea Chronic HFpEF 55% On 4LNC at baseline, clinical dehydrated CXR nonacute but low lung volumes Held home bumex, lasix, lisinopril; continue ASA metoprolol CHF meds COVID positive, started decadron and albuterol MDI Weaned back to home O2 Recommend outpatient sleep medicine follow-up for CPAP adjustment/titration   DM type 2 Peripheral neuropathy HbA1c 7.4 Started diabetic diet and decadron for COVID On gabapentin for neuropathy Follow glucose closely Continue lantus 65 units nightly as at home with scheduled Humalog with SSI TIDAC   CAD Elevated troponin Denies chest pain, trop 26>22 Suspect elevated trop due to poor renal clearance with AKI Checking EKG Continue home ASA, lipitor, and metoprolol   History of DVT/PE Chronic anticoagulation with Coumadin Pharmacy consulted for daily dosing Continue home coumadin regimen  Dementia Continue home aricept   Depression Continue home zoloft and wellbutrin   Morbid obesity BMI 44.60 Lifestyle modification recommended
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Dehydration, Diabetic diet, Diuretic therapy, Dyspnoea
Clinical narrative: Patient is a 74 y.o. male patient with history of Hypertension, diabetes, morbid obesity, OSA presented with shortness of breath.  He was found to be COVID positive and briefly required BIPAP and was able to be quickly weaned back to his home O2.  He was seen by Pulmonology and is stable for discharge from their standpoint.  He also was noted to have HAGMA, LA and AKI which all resolved with IVF.  PT and OT were consulted and family requesting HHC.  He is otherwise stable for discharge home and outpatient follow-up as above.  All questions and concerns answered at bedside with patient and his wife present.     Sepsis present on admit Covid-19 Virus Infection SIRS on admit, lactate 3.1, with AKI Hemodynamics stable and given CHF/COVID will avoid 30 ml/kg bolus Will hydrate with maintenance IVF and follow lactate, hemodynamics, and SCr closely Date of onset of symptoms: 10/3/22 Symptoms present on admission: cough, dyspnea Date of covid positive test: 10/4/2022 Vaccination status: vaccinated and 1 booster Imaging: CXR nonacute but low lung volumes. No definite focal consolidation Oxygen requirements on admission: 4LNC home O2 baseline Current oxygen requirements: Was on BiPAP now back to home O2 at 4 L NC Medical therapy: decadron remdesivir, albuterol MDI, guaifenesin/dextromethorphan Consultants following: None  Anticipated special isolation end date: 10/14/2022 CRP 64 Procalcitonin wnl Discharge on dexamethasone to complete 10 days steroid course   Lactic acidosis, resolved Lactic acid 4.3 now down to 3.4 Resolved with IVF   Acute renal failure, resolved SCr 1.68 from baseline 0.8-1.0 Due to COVID infection and home diuretics, ACEi Held home lasix, bumex, and lisinopril Avoid nephrotoxins, and provide gentle IVF hydration, encourage PO intake SCr normalized with IVF Can resume home regimen on discharge  Acute on Chronic respiratory failure Obesity hypoventilation syndrome Obstructive sleep apnea Chronic HFpEF 55% On 4LNC at baseline, clinical dehydrated CXR nonacute but low lung volumes Held home bumex, lasix, lisinopril; continue ASA metoprolol CHF meds COVID positive, started decadron and albuterol MDI Weaned back to home O2 Recommend outpatient sleep medicine follow-up for CPAP adjustment/titration   DM type 2 Peripheral neuropathy HbA1c 7.4 Started diabetic diet and decadron for COVID On gabapentin for neuropathy Follow glucose closely Continue lantus 65 units nightly as at home with scheduled Humalog with SSI TIDAC   CAD Elevated troponin Denies chest pain, trop 26>22 Suspect elevated trop due to poor renal clearance with AKI Checking EKG Continue home ASA, lipitor, and metoprolol   History of DVT/PE Chronic anticoagulation with Coumadin Pharmacy consulted for daily dosing Continue home coumadin regimen  Dementia Continue home aricept   Depression Continue home zoloft and wellbutrin   Morbid obesity BMI 44.60 Lifestyle modification recommended
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Glycosylated haemoglobin increased, Lactic acidosis, Metabolic acidosis, Neuropathy peripheral, Obstructive sleep apnoea syndrome
Clinical narrative: Patient is a 74 y.o. male patient with history of Hypertension, diabetes, morbid obesity, OSA presented with shortness of breath.  He was found to be COVID positive and briefly required BIPAP and was able to be quickly weaned back to his home O2.  He was seen by Pulmonology and is stable for discharge from their standpoint.  He also was noted to have HAGMA, LA and AKI which all resolved with IVF.  PT and OT were consulted and family requesting HHC.  He is otherwise stable for discharge home and outpatient follow-up as above.  All questions and concerns answered at bedside with patient and his wife present.     Sepsis present on admit Covid-19 Virus Infection SIRS on admit, lactate 3.1, with AKI Hemodynamics stable and given CHF/COVID will avoid 30 ml/kg bolus Will hydrate with maintenance IVF and follow lactate, hemodynamics, and SCr closely Date of onset of symptoms: 10/3/22 Symptoms present on admission: cough, dyspnea Date of covid positive test: 10/4/2022 Vaccination status: vaccinated and 1 booster Imaging: CXR nonacute but low lung volumes. No definite focal consolidation Oxygen requirements on admission: 4LNC home O2 baseline Current oxygen requirements: Was on BiPAP now back to home O2 at 4 L NC Medical therapy: decadron remdesivir, albuterol MDI, guaifenesin/dextromethorphan Consultants following: None  Anticipated special isolation end date: 10/14/2022 CRP 64 Procalcitonin wnl Discharge on dexamethasone to complete 10 days steroid course   Lactic acidosis, resolved Lactic acid 4.3 now down to 3.4 Resolved with IVF   Acute renal failure, resolved SCr 1.68 from baseline 0.8-1.0 Due to COVID infection and home diuretics, ACEi Held home lasix, bumex, and lisinopril Avoid nephrotoxins, and provide gentle IVF hydration, encourage PO intake SCr normalized with IVF Can resume home regimen on discharge  Acute on Chronic respiratory failure Obesity hypoventilation syndrome Obstructive sleep apnea Chronic HFpEF 55% On 4LNC at baseline, clinical dehydrated CXR nonacute but low lung volumes Held home bumex, lasix, lisinopril; continue ASA metoprolol CHF meds COVID positive, started decadron and albuterol MDI Weaned back to home O2 Recommend outpatient sleep medicine follow-up for CPAP adjustment/titration   DM type 2 Peripheral neuropathy HbA1c 7.4 Started diabetic diet and decadron for COVID On gabapentin for neuropathy Follow glucose closely Continue lantus 65 units nightly as at home with scheduled Humalog with SSI TIDAC   CAD Elevated troponin Denies chest pain, trop 26>22 Suspect elevated trop due to poor renal clearance with AKI Checking EKG Continue home ASA, lipitor, and metoprolol   History of DVT/PE Chronic anticoagulation with Coumadin Pharmacy consulted for daily dosing Continue home coumadin regimen  Dementia Continue home aricept   Depression Continue home zoloft and wellbutrin   Morbid obesity BMI 44.60 Lifestyle modification recommended
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Pickwickian syndrome, Positive airway pressure therapy, Procalcitonin normal, SARS-CoV-2 test positive, Sepsis
Clinical narrative: Patient is a 74 y.o. male patient with history of Hypertension, diabetes, morbid obesity, OSA presented with shortness of breath.  He was found to be COVID positive and briefly required BIPAP and was able to be quickly weaned back to his home O2.  He was seen by Pulmonology and is stable for discharge from their standpoint.  He also was noted to have HAGMA, LA and AKI which all resolved with IVF.  PT and OT were consulted and family requesting HHC.  He is otherwise stable for discharge home and outpatient follow-up as above.  All questions and concerns answered at bedside with patient and his wife present.     Sepsis present on admit Covid-19 Virus Infection SIRS on admit, lactate 3.1, with AKI Hemodynamics stable and given CHF/COVID will avoid 30 ml/kg bolus Will hydrate with maintenance IVF and follow lactate, hemodynamics, and SCr closely Date of onset of symptoms: 10/3/22 Symptoms present on admission: cough, dyspnea Date of covid positive test: 10/4/2022 Vaccination status: vaccinated and 1 booster Imaging: CXR nonacute but low lung volumes. No definite focal consolidation Oxygen requirements on admission: 4LNC home O2 baseline Current oxygen requirements: Was on BiPAP now back to home O2 at 4 L NC Medical therapy: decadron remdesivir, albuterol MDI, guaifenesin/dextromethorphan Consultants following: None  Anticipated special isolation end date: 10/14/2022 CRP 64 Procalcitonin wnl Discharge on dexamethasone to complete 10 days steroid course   Lactic acidosis, resolved Lactic acid 4.3 now down to 3.4 Resolved with IVF   Acute renal failure, resolved SCr 1.68 from baseline 0.8-1.0 Due to COVID infection and home diuretics, ACEi Held home lasix, bumex, and lisinopril Avoid nephrotoxins, and provide gentle IVF hydration, encourage PO intake SCr normalized with IVF Can resume home regimen on discharge  Acute on Chronic respiratory failure Obesity hypoventilation syndrome Obstructive sleep apnea Chronic HFpEF 55% On 4LNC at baseline, clinical dehydrated CXR nonacute but low lung volumes Held home bumex, lasix, lisinopril; continue ASA metoprolol CHF meds COVID positive, started decadron and albuterol MDI Weaned back to home O2 Recommend outpatient sleep medicine follow-up for CPAP adjustment/titration   DM type 2 Peripheral neuropathy HbA1c 7.4 Started diabetic diet and decadron for COVID On gabapentin for neuropathy Follow glucose closely Continue lantus 65 units nightly as at home with scheduled Humalog with SSI TIDAC   CAD Elevated troponin Denies chest pain, trop 26>22 Suspect elevated trop due to poor renal clearance with AKI Checking EKG Continue home ASA, lipitor, and metoprolol   History of DVT/PE Chronic anticoagulation with Coumadin Pharmacy consulted for daily dosing Continue home coumadin regimen  Dementia Continue home aricept   Depression Continue home zoloft and wellbutrin   Morbid obesity BMI 44.60 Lifestyle modification recommended
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Systemic inflammatory response syndrome, Total lung capacity decreased, Troponin increased, Type 2 diabetes mellitus
Clinical narrative: Patient is a 74 y.o. male patient with history of Hypertension, diabetes, morbid obesity, OSA presented with shortness of breath.  He was found to be COVID positive and briefly required BIPAP and was able to be quickly weaned back to his home O2.  He was seen by Pulmonology and is stable for discharge from their standpoint.  He also was noted to have HAGMA, LA and AKI which all resolved with IVF.  PT and OT were consulted and family requesting HHC.  He is otherwise stable for discharge home and outpatient follow-up as above.  All questions and concerns answered at bedside with patient and his wife present.     Sepsis present on admit Covid-19 Virus Infection SIRS on admit, lactate 3.1, with AKI Hemodynamics stable and given CHF/COVID will avoid 30 ml/kg bolus Will hydrate with maintenance IVF and follow lactate, hemodynamics, and SCr closely Date of onset of symptoms: 10/3/22 Symptoms present on admission: cough, dyspnea Date of covid positive test: 10/4/2022 Vaccination status: vaccinated and 1 booster Imaging: CXR nonacute but low lung volumes. No definite focal consolidation Oxygen requirements on admission: 4LNC home O2 baseline Current oxygen requirements: Was on BiPAP now back to home O2 at 4 L NC Medical therapy: decadron remdesivir, albuterol MDI, guaifenesin/dextromethorphan Consultants following: None  Anticipated special isolation end date: 10/14/2022 CRP 64 Procalcitonin wnl Discharge on dexamethasone to complete 10 days steroid course   Lactic acidosis, resolved Lactic acid 4.3 now down to 3.4 Resolved with IVF   Acute renal failure, resolved SCr 1.68 from baseline 0.8-1.0 Due to COVID infection and home diuretics, ACEi Held home lasix, bumex, and lisinopril Avoid nephrotoxins, and provide gentle IVF hydration, encourage PO intake SCr normalized with IVF Can resume home regimen on discharge  Acute on Chronic respiratory failure Obesity hypoventilation syndrome Obstructive sleep apnea Chronic HFpEF 55% On 4LNC at baseline, clinical dehydrated CXR nonacute but low lung volumes Held home bumex, lasix, lisinopril; continue ASA metoprolol CHF meds COVID positive, started decadron and albuterol MDI Weaned back to home O2 Recommend outpatient sleep medicine follow-up for CPAP adjustment/titration   DM type 2 Peripheral neuropathy HbA1c 7.4 Started diabetic diet and decadron for COVID On gabapentin for neuropathy Follow glucose closely Continue lantus 65 units nightly as at home with scheduled Humalog with SSI TIDAC   CAD Elevated troponin Denies chest pain, trop 26>22 Suspect elevated trop due to poor renal clearance with AKI Checking EKG Continue home ASA, lipitor, and metoprolol   History of DVT/PE Chronic anticoagulation with Coumadin Pharmacy consulted for daily dosing Continue home coumadin regimen  Dementia Continue home aricept   Depression Continue home zoloft and wellbutrin   Morbid obesity BMI 44.60 Lifestyle modification recommended
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Depression, Weight increased
Clinical narrative: After received my 2nd shot  I went into a deep depression that I am still struggling to get out of. Additionally, since getting the second shot I have gained 45lbs. In approx 16 months.
Age: 69.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient was inadvertently administered the bivalent Pfizer bivalent COVID-19 immunization instead of the monovalent immunization. Patient had not received their primary series.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chills, Dizziness, Fatigue, Pyrexia
Clinical narrative: in the 36 hours after the vaccine, I had a high fever (102), chills, fatigues and dizzy spells.  On July 26, 2022 I tested positive for COVID.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: in the 36 hours after the vaccine, I had a high fever (102), chills, fatigues and dizzy spells.  On July 26, 2022 I tested positive for COVID.
Age: 64.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Chills, Pain, Pain in extremity, Pyrexia
Clinical narrative: Fever, chills, body aches, sore arm
Age: 12.0
Sex: M
Vaccine: DTAPHEPBIP
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: MA administered pediarix to a 12 year old pt.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Blood thyroid stimulating hormone, Thyroid function test, Thyroiditis subacute, Thyroxine
Clinical narrative: Subacute thyroidoisis without thyroid storm
Age: 14.0
Sex: F
Vaccine: FLU4
Symptoms: Ear discomfort, Nausea, Pallor, Paraesthesia, Syncope
Clinical narrative: At 11:59 a.m., the patient's younger brother reported to RN, that patient had fainted. RN witnessed patient supine on the floor, with her head in her mother's lap. Patient's head was placed flat on the floor and her  feet were elevated on a box. Patient's face was pale, but she was not in respiratory distress, and she was responsive to questioning. No hives, swelling of lips/face, no complaints of throat tightening, or itching. Patient did report burning ears, tingling hands, and slight nausea. Vital signs at 12:03 p.m.: blood pressure (BP) 126/76 mmHg, pulse (P) 84 beats/minutes, and respirations 22 minute. At 12:08 p.m., BP 118/70 mmHg, P 66 beats/min, and R 18. Patient stated she had not eaten breaksfast this morning. She was assisted to a sitting position on the floow and was given fruit punch and a protein Bar. At 12:21, Patient was assisted to a chair. At 1224, BP110/68, P60, R16. At 12:25pm, Patient stated she felt better. At 12:30 pm, she was assisted to her feet by her parents. Patient stated she felt fine.
Age: 61.0
Sex: F
Vaccine: FLUC4
Symptoms: Arthralgia, Hypoaesthesia, Injection site pain, Neck pain, Pain in extremity
Clinical narrative: I have pain in my left arm, shoulder and neck.  It hurts to touch parts of my left arm.  I also have tingling and numbness that radiates from the down my arm to my fingers and pain in the joint at the base of my thumb.
Age: 61.0
Sex: F
Vaccine: FLUC4
Symptoms: Paraesthesia
Clinical narrative: I have pain in my left arm, shoulder and neck.  It hurts to touch parts of my left arm.  I also have tingling and numbness that radiates from the down my arm to my fingers and pain in the joint at the base of my thumb.
Age: 55.0
Sex: F
Vaccine: COVID19, FLUX
Symptoms: Aphonia, Chills, Conjunctivitis, Cough, Fatigue
Clinical narrative: On Sunday night I started feeling achy and tired. On Monday I woke up with no voice and that night I started having fever, chills, and bad cough. I went to the doctor where I work, and they prescribed me promethazine-dm which did nothing for the cough. On Tuesday I had a stuffing head and running nose. I had no voice for a week straight. I also took Sudafed and that did not work either. So, I called my doctor, and she prescribed Amoxicillin. Two days later I started to feel better but then I woke up with pink eye.
Age: 55.0
Sex: F
Vaccine: COVID19, FLUX
Symptoms: Head discomfort, Pain, Pyrexia, Rhinorrhoea, SARS-CoV-2 test negative
Clinical narrative: On Sunday night I started feeling achy and tired. On Monday I woke up with no voice and that night I started having fever, chills, and bad cough. I went to the doctor where I work, and they prescribed me promethazine-dm which did nothing for the cough. On Tuesday I had a stuffing head and running nose. I had no voice for a week straight. I also took Sudafed and that did not work either. So, I called my doctor, and she prescribed Amoxicillin. Two days later I started to feel better but then I woke up with pink eye.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Tenderness, Testicular mass, Testicular pain
Clinical narrative: Prior to the covid vaccine, I didn't have any testicular pain or any lumps. After receiving my first dose I noticed I started to develop pain on my right testicle and a small tender lump. This issue started approximately 13 days after my vaccine and is still present.
Age: 9.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect dose administered, Product administered to patient of inappropriate age
Clinical narrative: Pt was Under age of 12 years and older to receive adult Pfizer vaccine.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, Chest X-ray abnormal, Computerised tomogram thorax abnormal, Condition aggravated
Clinical narrative: A 78 y.o. male patient of, MD with a history of past Medical History: Diagnosis; Date; Cancer (HCC); prostate COPD (chronic obstructive pulmonary disease) (HCC); Diabetes mellitus (HCC); Diabetic retinopathy (HCC) Hyperlipidemia; Hypertension; Neuropathy; Sleep apnea. A 78-year-old man admitted to Hospital on October 16, 2022 with dyspnea.  Found to have COVID-19 and superimposed right middle lobe pneumonia.  Symptoms started around October 12.  Symptoms present on admission included mild hypoxemia, cough and dyspnea.  COVID-positive test was done on October 16, 2022.  Patient's vaccination status included 2 vaccines and 1 booster for COVID-19.  Chest x-ray pulmonary CT and interval change chest x-ray all demonstrate stable right middle lobe pneumonia likely secondary to COVID-19.  Treating as CAP with azithromycin and cefdinir to complete antibiotic course on discharge.  Patient did need intermittent supplemental oxygen at 2 L per nasal cannula for O2 sats in the mid to high 80s at the lowest.  Of note patient also has underlying COPD.  Patient initially received steroids.  Patient also has known history of hypertension.  His hydrochlorothiazide was stopped during hospitalization and was not continued on discharge secondary to hyponatremia and hypokalemia.  Can have a risk-benefit discussion with PCP about reinitiating this as an outpatient.  MRSA, strep pneumonia, Legionella all negative.  Urine culture was never collected due to nonproductive cough.  Patient was encouraged to continue to use his incentive spirometer. Discharge Diagnoses: 1 right lower lobe pneumonia; COVID-19 virus; Acute hypoxemic respiratory failure; Type 2 diabetes; History of COPD  Hypertension; Hyperlipidemia; Leukocytosis; Hyponatremia; Hypokalemia.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Dyspnoea, Hyperlipidaemia, Hypertension, Hypokalaemia
Clinical narrative: A 78 y.o. male patient of, MD with a history of past Medical History: Diagnosis; Date; Cancer (HCC); prostate COPD (chronic obstructive pulmonary disease) (HCC); Diabetes mellitus (HCC); Diabetic retinopathy (HCC) Hyperlipidemia; Hypertension; Neuropathy; Sleep apnea. A 78-year-old man admitted to Hospital on October 16, 2022 with dyspnea.  Found to have COVID-19 and superimposed right middle lobe pneumonia.  Symptoms started around October 12.  Symptoms present on admission included mild hypoxemia, cough and dyspnea.  COVID-positive test was done on October 16, 2022.  Patient's vaccination status included 2 vaccines and 1 booster for COVID-19.  Chest x-ray pulmonary CT and interval change chest x-ray all demonstrate stable right middle lobe pneumonia likely secondary to COVID-19.  Treating as CAP with azithromycin and cefdinir to complete antibiotic course on discharge.  Patient did need intermittent supplemental oxygen at 2 L per nasal cannula for O2 sats in the mid to high 80s at the lowest.  Of note patient also has underlying COPD.  Patient initially received steroids.  Patient also has known history of hypertension.  His hydrochlorothiazide was stopped during hospitalization and was not continued on discharge secondary to hyponatremia and hypokalemia.  Can have a risk-benefit discussion with PCP about reinitiating this as an outpatient.  MRSA, strep pneumonia, Legionella all negative.  Urine culture was never collected due to nonproductive cough.  Patient was encouraged to continue to use his incentive spirometer. Discharge Diagnoses: 1 right lower lobe pneumonia; COVID-19 virus; Acute hypoxemic respiratory failure; Type 2 diabetes; History of COPD  Hypertension; Hyperlipidemia; Leukocytosis; Hyponatremia; Hypokalemia.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Hyponatraemia, Hypoxia, Incentive spirometry, Legionella test, Leukocytosis
Clinical narrative: A 78 y.o. male patient of, MD with a history of past Medical History: Diagnosis; Date; Cancer (HCC); prostate COPD (chronic obstructive pulmonary disease) (HCC); Diabetes mellitus (HCC); Diabetic retinopathy (HCC) Hyperlipidemia; Hypertension; Neuropathy; Sleep apnea. A 78-year-old man admitted to Hospital on October 16, 2022 with dyspnea.  Found to have COVID-19 and superimposed right middle lobe pneumonia.  Symptoms started around October 12.  Symptoms present on admission included mild hypoxemia, cough and dyspnea.  COVID-positive test was done on October 16, 2022.  Patient's vaccination status included 2 vaccines and 1 booster for COVID-19.  Chest x-ray pulmonary CT and interval change chest x-ray all demonstrate stable right middle lobe pneumonia likely secondary to COVID-19.  Treating as CAP with azithromycin and cefdinir to complete antibiotic course on discharge.  Patient did need intermittent supplemental oxygen at 2 L per nasal cannula for O2 sats in the mid to high 80s at the lowest.  Of note patient also has underlying COPD.  Patient initially received steroids.  Patient also has known history of hypertension.  His hydrochlorothiazide was stopped during hospitalization and was not continued on discharge secondary to hyponatremia and hypokalemia.  Can have a risk-benefit discussion with PCP about reinitiating this as an outpatient.  MRSA, strep pneumonia, Legionella all negative.  Urine culture was never collected due to nonproductive cough.  Patient was encouraged to continue to use his incentive spirometer. Discharge Diagnoses: 1 right lower lobe pneumonia; COVID-19 virus; Acute hypoxemic respiratory failure; Type 2 diabetes; History of COPD  Hypertension; Hyperlipidemia; Leukocytosis; Hyponatremia; Hypokalemia.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Pneumonia, SARS-CoV-2 test positive, Staphylococcus test negative, Streptococcus test negative, Superinfection
Clinical narrative: A 78 y.o. male patient of, MD with a history of past Medical History: Diagnosis; Date; Cancer (HCC); prostate COPD (chronic obstructive pulmonary disease) (HCC); Diabetes mellitus (HCC); Diabetic retinopathy (HCC) Hyperlipidemia; Hypertension; Neuropathy; Sleep apnea. A 78-year-old man admitted to Hospital on October 16, 2022 with dyspnea.  Found to have COVID-19 and superimposed right middle lobe pneumonia.  Symptoms started around October 12.  Symptoms present on admission included mild hypoxemia, cough and dyspnea.  COVID-positive test was done on October 16, 2022.  Patient's vaccination status included 2 vaccines and 1 booster for COVID-19.  Chest x-ray pulmonary CT and interval change chest x-ray all demonstrate stable right middle lobe pneumonia likely secondary to COVID-19.  Treating as CAP with azithromycin and cefdinir to complete antibiotic course on discharge.  Patient did need intermittent supplemental oxygen at 2 L per nasal cannula for O2 sats in the mid to high 80s at the lowest.  Of note patient also has underlying COPD.  Patient initially received steroids.  Patient also has known history of hypertension.  His hydrochlorothiazide was stopped during hospitalization and was not continued on discharge secondary to hyponatremia and hypokalemia.  Can have a risk-benefit discussion with PCP about reinitiating this as an outpatient.  MRSA, strep pneumonia, Legionella all negative.  Urine culture was never collected due to nonproductive cough.  Patient was encouraged to continue to use his incentive spirometer. Discharge Diagnoses: 1 right lower lobe pneumonia; COVID-19 virus; Acute hypoxemic respiratory failure; Type 2 diabetes; History of COPD  Hypertension; Hyperlipidemia; Leukocytosis; Hyponatremia; Hypokalemia.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Type 2 diabetes mellitus
Clinical narrative: A 78 y.o. male patient of, MD with a history of past Medical History: Diagnosis; Date; Cancer (HCC); prostate COPD (chronic obstructive pulmonary disease) (HCC); Diabetes mellitus (HCC); Diabetic retinopathy (HCC) Hyperlipidemia; Hypertension; Neuropathy; Sleep apnea. A 78-year-old man admitted to Hospital on October 16, 2022 with dyspnea.  Found to have COVID-19 and superimposed right middle lobe pneumonia.  Symptoms started around October 12.  Symptoms present on admission included mild hypoxemia, cough and dyspnea.  COVID-positive test was done on October 16, 2022.  Patient's vaccination status included 2 vaccines and 1 booster for COVID-19.  Chest x-ray pulmonary CT and interval change chest x-ray all demonstrate stable right middle lobe pneumonia likely secondary to COVID-19.  Treating as CAP with azithromycin and cefdinir to complete antibiotic course on discharge.  Patient did need intermittent supplemental oxygen at 2 L per nasal cannula for O2 sats in the mid to high 80s at the lowest.  Of note patient also has underlying COPD.  Patient initially received steroids.  Patient also has known history of hypertension.  His hydrochlorothiazide was stopped during hospitalization and was not continued on discharge secondary to hyponatremia and hypokalemia.  Can have a risk-benefit discussion with PCP about reinitiating this as an outpatient.  MRSA, strep pneumonia, Legionella all negative.  Urine culture was never collected due to nonproductive cough.  Patient was encouraged to continue to use his incentive spirometer. Discharge Diagnoses: 1 right lower lobe pneumonia; COVID-19 virus; Acute hypoxemic respiratory failure; Type 2 diabetes; History of COPD  Hypertension; Hyperlipidemia; Leukocytosis; Hyponatremia; Hypokalemia.
Age: 0.58
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Pt was mistakenly given pfizer bivalent for his first Covid-19 injection.  No adverse effect.  Pt's mom was called the following day and 5 days later to check on the patient.  Pt had no adverse reactions.
Age: 31.0
Sex: M
Vaccine: COVID19-2, FLUR4, TDAP
Symptoms: Fall, Fatigue, Pallor, Syncope
Clinical narrative: Patient was in the pharmacy around 11:30AM for Flublok, Boostrix, and Pfizer bivalent. After the vaccines, pharmacist advised patient to stay in the store for 15 minutes. A moment later, patient fainted at the shelf-checkout in the front near customer service. Manager on duty heard the fall and came over. Patient regained consciousness right away. A customer nearby claimed to be a nurse advised patient to be seated. Manager gave the patient some water and the patient claimed to feel fine. Pharmacist came to offer additional assistance, but patient refused and claimed to be okay. The patient looked very tired and pale, few minutes later patient left store and refused further assistance.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Blood creatine phosphokinase increased, Gait disturbance, Grip strength decreased
Clinical narrative: 11.5.22 date of vaccination  11.6.22 sore deltoid  11.7.22 sore neck and shoulders  11.8.22 whole body aches, difficulty walking up stairs, 11.9.22 weakness, tremors, continuation of whole body aches, pain with movement of any muscle group 11.10.22 dropping items, grip weakness, whole body aches, continued painful muscle movements of all muscle groups  11.11.22 ER visit. Rhabdomyolysis diagnosis. Hospital admission
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Neck pain, Pain, Rhabdomyolysis, Tremor
Clinical narrative: 11.5.22 date of vaccination  11.6.22 sore deltoid  11.7.22 sore neck and shoulders  11.8.22 whole body aches, difficulty walking up stairs, 11.9.22 weakness, tremors, continuation of whole body aches, pain with movement of any muscle group 11.10.22 dropping items, grip weakness, whole body aches, continued painful muscle movements of all muscle groups  11.11.22 ER visit. Rhabdomyolysis diagnosis. Hospital admission
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Breath sounds abnormal, Bronchitis, COVID-19, COVID-19 pneumonia
Clinical narrative: 10/25/2022: presenting with hypoxia and a UTI. Found to be hypoxic in the 70s,  placed on oxygen.  Chronic indwelling Foley catheters. Her urine bag is actually purple.  Coarse breath sounds bilaterally, given a DuoNeb for COPD as considered. She also had some phlegm production with cough.Will treat her for COPD with bronchitis. She was covered with doxycycline. UA does show evidence of infection. She was given Rocephin.   Principal Problem: Pneumonia due to COVID-19 virus Active Problems: COPD exacerbation, Urinary retention with incomplete bladder emptying Urinary tract infection associated with indwelling urethral catheter,   Plan ? Admit to telemetry, continuous pulse oximetry, keep on oxygen by NC 5 L/min, wean as tolerated ?IV Decadron 6 mg daily for at least 6 days ? Due to CKD 3,borderline creatinine clearance of 29.4, will hold off on giving IV remdesivir tonight and give 500 cc bolus NS to assess improvement in renal function by tomorrow morning ? Can consider resuming IV remdesivir when renal function stabilizes in AM, in consultation with ID ? Pulmonology on consult ? Albuterol as needed for wheezing via MDI, Robittusin as need for cough. Intermittent gentle suction ? Heparin for DVT prophylaxis ?Check D-dimers, ESR, CRP COVID-19 pneumonia with hypoxia: With significant oxygen requirement and desaturation on admission in 70s. We proceeded with CT chest, found to have pulmonary embolism in the right lung. -Supplemental O2, wean as tolerated -Monitor inflammatory markers intermittently -Started on dexamethasone and remdesivir. -Solu-Medrol 125 mg IV given on admission -Symptom onset approximately on 10/24/2022, isolation duration to be determined  Patient expired of covid-19 pneumonia and hypoxia 11/1/2022 at 20:40  11/2: Follow up note on hospital course: Patient diagnosed with COVID-19 with hypoxia. Patient underwent CT chest and showed right-sided pulmonary embolism. After discussion of risk and benefit, patient was started on Lovenox and dexamethasone. She also qualified for remdesivir. Patient initially was stable however started having massive GI bleeding. Patient with poor overall prognosis, poor quality of life at baseline, has advanced Alzheimer's dementia. Patient transition to hospice care after discussion.   Submitter does not have access to full medical record. If further details are needed, please contact Hospital.
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray normal, Chromaturia, Chronic obstructive pulmonary disease, Computerised tomogram thorax abnormal, Condition aggravated
Clinical narrative: 10/25/2022: presenting with hypoxia and a UTI. Found to be hypoxic in the 70s,  placed on oxygen.  Chronic indwelling Foley catheters. Her urine bag is actually purple.  Coarse breath sounds bilaterally, given a DuoNeb for COPD as considered. She also had some phlegm production with cough.Will treat her for COPD with bronchitis. She was covered with doxycycline. UA does show evidence of infection. She was given Rocephin.   Principal Problem: Pneumonia due to COVID-19 virus Active Problems: COPD exacerbation, Urinary retention with incomplete bladder emptying Urinary tract infection associated with indwelling urethral catheter,   Plan ? Admit to telemetry, continuous pulse oximetry, keep on oxygen by NC 5 L/min, wean as tolerated ?IV Decadron 6 mg daily for at least 6 days ? Due to CKD 3,borderline creatinine clearance of 29.4, will hold off on giving IV remdesivir tonight and give 500 cc bolus NS to assess improvement in renal function by tomorrow morning ? Can consider resuming IV remdesivir when renal function stabilizes in AM, in consultation with ID ? Pulmonology on consult ? Albuterol as needed for wheezing via MDI, Robittusin as need for cough. Intermittent gentle suction ? Heparin for DVT prophylaxis ?Check D-dimers, ESR, CRP COVID-19 pneumonia with hypoxia: With significant oxygen requirement and desaturation on admission in 70s. We proceeded with CT chest, found to have pulmonary embolism in the right lung. -Supplemental O2, wean as tolerated -Monitor inflammatory markers intermittently -Started on dexamethasone and remdesivir. -Solu-Medrol 125 mg IV given on admission -Symptom onset approximately on 10/24/2022, isolation duration to be determined  Patient expired of covid-19 pneumonia and hypoxia 11/1/2022 at 20:40  11/2: Follow up note on hospital course: Patient diagnosed with COVID-19 with hypoxia. Patient underwent CT chest and showed right-sided pulmonary embolism. After discussion of risk and benefit, patient was started on Lovenox and dexamethasone. She also qualified for remdesivir. Patient initially was stable however started having massive GI bleeding. Patient with poor overall prognosis, poor quality of life at baseline, has advanced Alzheimer's dementia. Patient transition to hospice care after discussion.   Submitter does not have access to full medical record. If further details are needed, please contact Hospital.
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Creatinine renal clearance, Death, Device related infection, Gastrointestinal haemorrhage, Hypoxia
Clinical narrative: 10/25/2022: presenting with hypoxia and a UTI. Found to be hypoxic in the 70s,  placed on oxygen.  Chronic indwelling Foley catheters. Her urine bag is actually purple.  Coarse breath sounds bilaterally, given a DuoNeb for COPD as considered. She also had some phlegm production with cough.Will treat her for COPD with bronchitis. She was covered with doxycycline. UA does show evidence of infection. She was given Rocephin.   Principal Problem: Pneumonia due to COVID-19 virus Active Problems: COPD exacerbation, Urinary retention with incomplete bladder emptying Urinary tract infection associated with indwelling urethral catheter,   Plan ? Admit to telemetry, continuous pulse oximetry, keep on oxygen by NC 5 L/min, wean as tolerated ?IV Decadron 6 mg daily for at least 6 days ? Due to CKD 3,borderline creatinine clearance of 29.4, will hold off on giving IV remdesivir tonight and give 500 cc bolus NS to assess improvement in renal function by tomorrow morning ? Can consider resuming IV remdesivir when renal function stabilizes in AM, in consultation with ID ? Pulmonology on consult ? Albuterol as needed for wheezing via MDI, Robittusin as need for cough. Intermittent gentle suction ? Heparin for DVT prophylaxis ?Check D-dimers, ESR, CRP COVID-19 pneumonia with hypoxia: With significant oxygen requirement and desaturation on admission in 70s. We proceeded with CT chest, found to have pulmonary embolism in the right lung. -Supplemental O2, wean as tolerated -Monitor inflammatory markers intermittently -Started on dexamethasone and remdesivir. -Solu-Medrol 125 mg IV given on admission -Symptom onset approximately on 10/24/2022, isolation duration to be determined  Patient expired of covid-19 pneumonia and hypoxia 11/1/2022 at 20:40  11/2: Follow up note on hospital course: Patient diagnosed with COVID-19 with hypoxia. Patient underwent CT chest and showed right-sided pulmonary embolism. After discussion of risk and benefit, patient was started on Lovenox and dexamethasone. She also qualified for remdesivir. Patient initially was stable however started having massive GI bleeding. Patient with poor overall prognosis, poor quality of life at baseline, has advanced Alzheimer's dementia. Patient transition to hospice care after discussion.   Submitter does not have access to full medical record. If further details are needed, please contact Hospital.
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza A virus test negative, Influenza B virus test, Oxygen saturation decreased, Productive cough, Pulmonary embolism
Clinical narrative: 10/25/2022: presenting with hypoxia and a UTI. Found to be hypoxic in the 70s,  placed on oxygen.  Chronic indwelling Foley catheters. Her urine bag is actually purple.  Coarse breath sounds bilaterally, given a DuoNeb for COPD as considered. She also had some phlegm production with cough.Will treat her for COPD with bronchitis. She was covered with doxycycline. UA does show evidence of infection. She was given Rocephin.   Principal Problem: Pneumonia due to COVID-19 virus Active Problems: COPD exacerbation, Urinary retention with incomplete bladder emptying Urinary tract infection associated with indwelling urethral catheter,   Plan ? Admit to telemetry, continuous pulse oximetry, keep on oxygen by NC 5 L/min, wean as tolerated ?IV Decadron 6 mg daily for at least 6 days ? Due to CKD 3,borderline creatinine clearance of 29.4, will hold off on giving IV remdesivir tonight and give 500 cc bolus NS to assess improvement in renal function by tomorrow morning ? Can consider resuming IV remdesivir when renal function stabilizes in AM, in consultation with ID ? Pulmonology on consult ? Albuterol as needed for wheezing via MDI, Robittusin as need for cough. Intermittent gentle suction ? Heparin for DVT prophylaxis ?Check D-dimers, ESR, CRP COVID-19 pneumonia with hypoxia: With significant oxygen requirement and desaturation on admission in 70s. We proceeded with CT chest, found to have pulmonary embolism in the right lung. -Supplemental O2, wean as tolerated -Monitor inflammatory markers intermittently -Started on dexamethasone and remdesivir. -Solu-Medrol 125 mg IV given on admission -Symptom onset approximately on 10/24/2022, isolation duration to be determined  Patient expired of covid-19 pneumonia and hypoxia 11/1/2022 at 20:40  11/2: Follow up note on hospital course: Patient diagnosed with COVID-19 with hypoxia. Patient underwent CT chest and showed right-sided pulmonary embolism. After discussion of risk and benefit, patient was started on Lovenox and dexamethasone. She also qualified for remdesivir. Patient initially was stable however started having massive GI bleeding. Patient with poor overall prognosis, poor quality of life at baseline, has advanced Alzheimer's dementia. Patient transition to hospice care after discussion.   Submitter does not have access to full medical record. If further details are needed, please contact Hospital.
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Renal impairment, Respiratory syncytial virus test negative, SARS-CoV-2 test positive, Urinary retention, Urinary tract infection
Clinical narrative: 10/25/2022: presenting with hypoxia and a UTI. Found to be hypoxic in the 70s,  placed on oxygen.  Chronic indwelling Foley catheters. Her urine bag is actually purple.  Coarse breath sounds bilaterally, given a DuoNeb for COPD as considered. She also had some phlegm production with cough.Will treat her for COPD with bronchitis. She was covered with doxycycline. UA does show evidence of infection. She was given Rocephin.   Principal Problem: Pneumonia due to COVID-19 virus Active Problems: COPD exacerbation, Urinary retention with incomplete bladder emptying Urinary tract infection associated with indwelling urethral catheter,   Plan ? Admit to telemetry, continuous pulse oximetry, keep on oxygen by NC 5 L/min, wean as tolerated ?IV Decadron 6 mg daily for at least 6 days ? Due to CKD 3,borderline creatinine clearance of 29.4, will hold off on giving IV remdesivir tonight and give 500 cc bolus NS to assess improvement in renal function by tomorrow morning ? Can consider resuming IV remdesivir when renal function stabilizes in AM, in consultation with ID ? Pulmonology on consult ? Albuterol as needed for wheezing via MDI, Robittusin as need for cough. Intermittent gentle suction ? Heparin for DVT prophylaxis ?Check D-dimers, ESR, CRP COVID-19 pneumonia with hypoxia: With significant oxygen requirement and desaturation on admission in 70s. We proceeded with CT chest, found to have pulmonary embolism in the right lung. -Supplemental O2, wean as tolerated -Monitor inflammatory markers intermittently -Started on dexamethasone and remdesivir. -Solu-Medrol 125 mg IV given on admission -Symptom onset approximately on 10/24/2022, isolation duration to be determined  Patient expired of covid-19 pneumonia and hypoxia 11/1/2022 at 20:40  11/2: Follow up note on hospital course: Patient diagnosed with COVID-19 with hypoxia. Patient underwent CT chest and showed right-sided pulmonary embolism. After discussion of risk and benefit, patient was started on Lovenox and dexamethasone. She also qualified for remdesivir. Patient initially was stable however started having massive GI bleeding. Patient with poor overall prognosis, poor quality of life at baseline, has advanced Alzheimer's dementia. Patient transition to hospice care after discussion.   Submitter does not have access to full medical record. If further details are needed, please contact Hospital.
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Urine analysis abnormal
Clinical narrative: 10/25/2022: presenting with hypoxia and a UTI. Found to be hypoxic in the 70s,  placed on oxygen.  Chronic indwelling Foley catheters. Her urine bag is actually purple.  Coarse breath sounds bilaterally, given a DuoNeb for COPD as considered. She also had some phlegm production with cough.Will treat her for COPD with bronchitis. She was covered with doxycycline. UA does show evidence of infection. She was given Rocephin.   Principal Problem: Pneumonia due to COVID-19 virus Active Problems: COPD exacerbation, Urinary retention with incomplete bladder emptying Urinary tract infection associated with indwelling urethral catheter,   Plan ? Admit to telemetry, continuous pulse oximetry, keep on oxygen by NC 5 L/min, wean as tolerated ?IV Decadron 6 mg daily for at least 6 days ? Due to CKD 3,borderline creatinine clearance of 29.4, will hold off on giving IV remdesivir tonight and give 500 cc bolus NS to assess improvement in renal function by tomorrow morning ? Can consider resuming IV remdesivir when renal function stabilizes in AM, in consultation with ID ? Pulmonology on consult ? Albuterol as needed for wheezing via MDI, Robittusin as need for cough. Intermittent gentle suction ? Heparin for DVT prophylaxis ?Check D-dimers, ESR, CRP COVID-19 pneumonia with hypoxia: With significant oxygen requirement and desaturation on admission in 70s. We proceeded with CT chest, found to have pulmonary embolism in the right lung. -Supplemental O2, wean as tolerated -Monitor inflammatory markers intermittently -Started on dexamethasone and remdesivir. -Solu-Medrol 125 mg IV given on admission -Symptom onset approximately on 10/24/2022, isolation duration to be determined  Patient expired of covid-19 pneumonia and hypoxia 11/1/2022 at 20:40  11/2: Follow up note on hospital course: Patient diagnosed with COVID-19 with hypoxia. Patient underwent CT chest and showed right-sided pulmonary embolism. After discussion of risk and benefit, patient was started on Lovenox and dexamethasone. She also qualified for remdesivir. Patient initially was stable however started having massive GI bleeding. Patient with poor overall prognosis, poor quality of life at baseline, has advanced Alzheimer's dementia. Patient transition to hospice care after discussion.   Submitter does not have access to full medical record. If further details are needed, please contact Hospital.
Age: 77.0
Sex: M
Vaccine: COVID19-2
Symptoms: Musculoskeletal stiffness, Peripheral swelling
Clinical narrative: Patient's wife came to report to us her husband still had a stick neck and swollen hands several weeks after vaccination. They report going to their provider and reporting this and their provider started them on prednisone 10mg to be taken daily. they state this has helped them.